| Serial Number | 90779965 |
| Word Mark | OLAGACT |
| Filing Date | Thursday, June 17, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Thursday, November 7, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 27, 2022 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use in the nature of monoclonal antibodies for medical purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 19, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Monday, June 21, 2021 | NEW APPLICATION ENTERED |
| Friday, September 3, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 10, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, February 15, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 15, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 15, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 12, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 12, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 19, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, August 19, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 19, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 19, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Friday, August 19, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 7, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 27, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 27, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 22, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, April 28, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 28, 2023 | SOU EXTENSION 1 FILED |
| Friday, April 28, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, May 2, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, August 2, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, November 17, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, November 17, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, November 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 29, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, November 29, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, November 30, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 5, 2024 | SOU EXTENSION 3 FILED |
| Friday, April 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 5, 2024 | SOU EXTENSION 3 GRANTED |
| Saturday, April 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 7, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 7, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 7, 2024 | SOU EXTENSION 4 GRANTED |
| Thursday, November 7, 2024 | SOU EXTENSION 4 FILED |